PANACREAS
This article needs additional citations for verification. (June 2023) |
Funding | |
---|---|
European Commission
Seventh Framework Programme | |
Project | |
Collaborative project | |
Grant agreement N° | |
256986 | |
Starting date | |
March1st, 2011 | |
Duration | |
5 years | |
Website | |
http://www.panacreas.eu[1] | |
Participants | |
UKB | Universitaetsklinikum Bonn[2] (coordinator) (GERMANY) |
UNIGE | Università degli Studi di Genova[3](ITALY) |
CSIC | Agencia Estatal Consejo Superior de Investigaciones Cientificas[4] (SPAIN) |
EPFL | t |
PANACREAS stands for “Integrating chemical approaches to treat
FP7
.
Summary
PDAC causes 34000 deaths per year in the EU alone.[14] Despite considerable research efforts in the past decades, conventional treatment approaches, including surgery, radiation, chemotherapy, and combinations of these, have close to no impact on the course of this aggressive neoplasm. Therefore, virtually all of the patients diagnosed with PC develop metastases and die[15]
Given this scenario, the search for new microenvironment
";
Expected results
The work proposed in this program meets the need to reverse-translate the clinical issues encountered in
PDAC progression and reduce mortality
.
Notes and references
- ^ [1] [dead link]
- ^ "UKB Startseite". Ukbonn.de. Retrieved 30 June 2022.
- ^ "UniGe.it". Unige.it. Retrieved 30 June 2022.
- ^ "Consejo Superior de Investigaciones Científicas - CSIC - csic.es". Csic.es. Retrieved 30 June 2022.
- ^ "Home". Epfl.ch. Retrieved 30 June 2022.
- ^ "Accueil". Chuv.ch. Retrieved 30 June 2022.
- ^ "| Portal Universidad de Sevilla". Us.es. Retrieved 30 June 2022.
- ^ "UniTrento". Unitn.it. Retrieved 30 June 2022.
- ^ "Home page". Sib.swiss. Retrieved 30 June 2022.
- ^ "Start". Lu.se. Retrieved 30 June 2022.
- ^ "Debiopharm". Debiopharm.com. Retrieved 30 June 2022.
- ^ [2] [dead link]
- ^ "ALTA". Altaweb.eu. Retrieved 30 June 2022.
- PMID 17287242.
- S2CID 24678972.
- PMID 19858397.